LINC01393 and glioblastoma: Further, we demonstrated in vitro and in vivo that LINC01393 indeed regulates NUSAP1 expression by acting as a competing endogenous RNA (ceRNA) against miR-128-3p, thereby activating the NF-κB pathway to promote the development and progression of GBM.